Core Viewpoint - NEXGEL, Inc. has rescheduled its fourth quarter and fiscal year 2025 financial results conference call to April 8, 2026, to provide shareholders with more details regarding a proposed transaction with Celularity Inc. [1] Company Overview - NEXGEL, Inc. is a leading provider of healthcare, beauty, and over-the-counter (OTC) products, specializing in ultra-gentle, high-water-content hydrogel products for various applications [3] - The company has been developing and manufacturing electron-beam, cross-linked hydrogels for over two decades and has established brands such as SilverSeal®, Hexagels®, Turfguard®, Kenkoderm®, and Silly George® [3] - NEXGEL maintains strategic contract manufacturing relationships with prominent consumer healthcare companies [3] Financial Reporting - The company will file its Annual Report on Form 10-K for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission on March 31, 2026 [2] - The details for the fourth quarter and full year 2025 financial results conference call are as follows: Date: April 8, 2026, Time: 4:30 P.M. ET, Live Call: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International) [3]